Validation of a Claims-Based Algorithm to Identify Major Congenital Malformations in Infants Using a Linked Claims-EMR Database


Packnett E1, Evans KA2, Henriques C2, Moynihan M2, Palmer L2
1Merative, Washington, DC, USA, 2Merative, Ann Arbor, MI, USA

OBJECTIVES: Regulators are increasingly requiring retrospective studies of safety of prenatal exposures to medication. Though claims-based algorithms identifying major congenital malformations (MCM) are available, these were validated in Medicaid patients and their performance in commercially-insured populations is unknown. This study’s objective was to validate claims-based algorithms to identify MCM in a commercially-insured population.

METHODS: Infants (< 1 year) with an inpatient claim indicating livebirth and evidence of an MCM between 1/1/2016 and 12/31/2020 in the MarketScan Claims-EMR Database were included in this study. Infants were required to have at least six EMR encounters in the first year of life. Those with chromosomal, genetic, or other congenital anomalies with known etiology (e.g., congenital syphilis) were excluded. Evidence of MCM in the claims and EMR was flagged overall and for 11 categories of MCM. Percent positive agreement (PPA) was calculated as the percent of patients with an MCM in claims with evidence of the same MCM in EMR. Clinical characteristics and healthcare resource use (HCRU) were compared in infants with and without validated MCM.

RESULTS: In total 683 infants with MCM were included in this study; 42.9% were female with mean age of 16 days (SD: 29) at MCM diagnosis. Overall PPA between claims and EMR for any MCM was 80.4%; with highest PPA found in infants with oro-facial clefts (100%), eye anomalies (90%), and congenital heart defects (86.9%). Lowest PPA were found in infants with abdominal wall defects (56.3%) and digestive system malformations (62.7%). PPA for all other MCM types exceeded 70%. Clinical characteristics and HCRU in infants with and without validated MCM were similar though more infants with validated MCM had a physician specialist inpatient admission.

CONCLUSIONS: The PPA between the claims and EMR databases was high, indicating claims-based algorithms identify MCM in infants with a high degree of specificity.

Conference/Value in Health Info

2024-05, ISPOR 2024, Atlanta, GA, USA

Value in Health, Volume 27, Issue 6, S1 (June 2024)




Study Approaches


No Additional Disease & Conditions/Specialized Treatment Areas

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now